Malta - English - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, fimbriae types, and, polio virus, inactivated, aluminium phosphate - suspension for injection in pre-filled syringe - diphtheria toxoid 2 iu tetanus toxoid 2 iu pertussis toxoid 2.5 µg filamentous haemagglutinin (fha) 5 µg pertactin 3 µg fimbriae types 2 and 3 5 µg polio virus type 1 inactivated 40 dagu polio virus type 2 inactivated 8 dagu polio virus type 3 inactivated 32 dagu aluminium phosphate 1.5 mg - vaccines

Malta - English - Medicines Authority

medical logistics ltd no 8, ivo muscat azzopardi street, st julians stj 1905, malta - diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, poliovirus, inactivated, type, mahoney strain, mef, saukett strain - suspension for injection in pre-filled syringe - diphtheria toxoid 2 international unit(s) ; tetanus toxoid 20 international unit(s) ; pertussis toxoid 8 microgram(s) ; filamentous haemagglutinin (fha) 8 microgram(s) ; pertactin 2.5 microgram(s) ; poliovirus (inactivated) type 1 (mahoney strain) 40 d antigen unit(s) ; poliovirus (inactivated) type 2 (mef-1 strain) 8 d antigen unit(s) ; poliovirus (inactivated) type 3 (saukett strain) 32 d antigen unit(s) - vaccines

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur sa, france - diphtheria toxoid,tetanus toxoid,pertussis toxoid,filamentous haemagglutinin,inactivated poliomyelitis virus type 1 (mahoney strain),inactivated poliomyelitis virus type 2 (mef-1 strain),inactivated poliomyelitis virus type 3 (saukett strain) - suspension for injection in pre-filled syringe - 30,40,25,25,40,8,32 iu, dagu,

Malta - English - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, poliovirus, inactivated, type, mahoney strain, mef, saukett strain - suspension for injection in pre-filled syringe - diphtheria toxoid 2 iu poliovirus (inactivated) type 3 (saukett strain) 32 dagu pertactin 2.5 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu tetanus toxoid 20 iu pertussis toxoid 8 µg filamentous haemagglutinin (fha) 8 µg - vaccines

Malta - English - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - suspension for injection in pre-filled syringe - diphtheria toxoid 2 iu tetanus toxoid 20 iu pertussis toxoid 2.5 µg filamentous haemagglutinin (fha) 5 µg pertactin 3 µg fimbriae types 2 and 3 5 µg poliomyelitis virus inactivated type 1 40 u poliomyelitis virus inactivated type 2 8 u poliomyelitis virus inactivated type 3 32 u aluminium phosphate 1.5 mg - vaccines

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, hepatitis b surface antigen, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) - suspension for i/m injection - not less than 20iu/0,5ml+ not less than 40iu/0,5ml+ 25mcg/0,5ml+ 25mcg/0,5ml+ 10mcg/0,5ml+ 40d antigen units/0,5ml+ 8d antigen units/0,5ml+ 32d antigen units/0,5ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, hepatitis b surface antigen, poliovirus (inactivated): type 1 (mahoney), type 2 (mef-1), type 3 (saukett) - suspension for i/m injection - not less than 20iu/0,5ml+ not less than 40iu/0,5ml+ 25mcg/0,5ml+ 25mcg/0,5ml+ 10mcg/0,5ml+ 40d antigen units/0,5ml+ 8d antigen units/0,5ml+ 32d antigen units/0,5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - tetanus toxoid diphtheria toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin polio virus type 1 inactivated polio virus type 2 inactivated polio virus type 3 inactivated adsorbed fimbriae types 2 + 3 - suspension for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - diphtheria toxoid, adsorbed 2 [iu] (nlt, equiv to 2 lf per dose); pertactin 3ug; pertussis filamentous haemagglutinin 5ug; pertussis fimbriae 2+3 5ug; pertussis toxoid, adsorbed 2.5ug; polio virus type 1 29 dagu (mahoney, by parallel line method (equiv to 40 dagu by sigmoid method)); polio virus type 2 7 dagu (mef 1, by parallel line method (equiv to 8 dagu by sigmoid method)); polio virus type 3 26 dagu (saukett, by parallel line method (equiv to 32 dagu by sigmoid method)); tetanus toxoid 20 [iu] (nlt, equiv to 5 lf per dose) - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 2 [iu] (nlt, equiv to 2 lf per dose) pertactin 3ug pertussis filamentous haemagglutinin 5ug pertussis fimbriae 2+3 5ug pertussis toxoid, adsorbed 2.5ug polio virus type 1 29 dagu (mahoney, by parallel line method (equiv to 40 dagu by sigmoid method)) polio virus type 2 7 dagu (mef 1, by parallel line method (equiv to 8 dagu by sigmoid method)) polio virus type 3 26 dagu (saukett, by parallel line method (equiv to 32 dagu by sigmoid method)) tetanus toxoid 20 [iu] (nlt, equiv to 5 lf per dose) excipient: aluminium phosphate ethanol phenoxyethanol polysorbate 80 water for injection - adacel® polio is indicated for active immunisation against diphtheria, tetanus, pertussis and poliomyelitis in adults, adolescents and children aged 4 years and older as a booster following primary immunisation. children 4-6 years of age should have already received four doses of dtpa and ipv or opv. adacel® polio is not intended for primary immunisation. adacel® polio may be administered during pregnancy for prevention of pertussis in young infants via transplacental antibody transfer from the pregnant woman to the fetus. the use of adacel® polio should be determined on the basis of official recommendations.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - diphtheria toxoid, adsorbed 60 iu/ml; pertactin 16 µg/ml;  ; pertussis filamentous haemagglutinin 50 µg/ml;  ; pertussis toxoid, adsorbed 50 µg/ml;  ; polio virus type 1 80 dagu/ml;  ; polio virus type 2 16 dagu/ml;  ; polio virus type 3 64 dagu/ml;  ; tetanus toxoid, adsorbed 80 iu/ml - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 60 iu/ml pertactin 16 µg/ml   pertussis filamentous haemagglutinin 50 µg/ml   pertussis toxoid, adsorbed 50 µg/ml   polio virus type 1 80 dagu/ml   polio virus type 2 16 dagu/ml   polio virus type 3 64 dagu/ml   tetanus toxoid, adsorbed 80 iu/ml excipient: aluminium hydroxide neomycin sulfate polymyxin b sulfate sodium chloride water for injection - infanrix®-ipv is indicated for active primary immunisation against diphtheria, tetanus, pertussis, and poliomyelitis. infanrix®-ipv is also indicated as a booster dose for children who have previously been immunised with dtp and polio antigens.